| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2020-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f523af685f92bb07f144ec703f0f6478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_143c3fc55a51ac512323679f85cf660f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c98c5cac33de9f675486dc372e2fde3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce8fba9dd0414f366e5c4b56ede376fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a6bd47030cba86bcb4d4bf52d5ad84e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_960460c2878483cbac10a2a487c24cf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_098c25bee7f4e1447eaa70f7133245d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efaabce8a90a5f2bac016529996bfa8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69c3611b9baad343ccf5d92131d317df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc78607ea212bb1adb2bb69c2986fafe |
| publicationDate |
2022-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I777214-B |
| titleOfInvention |
Thienopyrimidine derivatives as acc inhibitors and uses thereof |
| abstract |
The present disclosure relates generally to compounds that bind to Acetyl-CoA Carboxylase (ACC) and act as inhibitors of ACC. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through binding of ACC，including liver diseases such as non-alcoholic fatty liver disase (NAFLD) and non-alcoholic steatohepatitis (NASH). |
| priorityDate |
2019-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |